PolyMedix Presents Data On Anti-Tuberculosis Activity Of Its Novel Antibiotic Compounds
PolyMedix, Inc. an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, presented new data at the "New Directions in AIDS Treatment Research Policy and Care Symposium" in New York on September 26th, 2008.
(more...)
(more...)